OKAY, maybe not make you smarter, but a new study out today says it may delay the onset of dementia – so same thing. We’re ordering a bottle today! No stock play. Metformin is generic now and sells for $4.00 a bottle. Needs a prescription though.

$4.00 for a wonder drug?

Better check your blood sugar, before you forget you read this. As many as 60% of patients with type 2 diabetes develop dementia. 


Metformin Use Tied to Slower Cognitive Decline, Less Dementia Risk.

New study adds evidence for T2D drug’s mental benefits

The study found that metformin use was associated with an 81% reduction in incident dementia risk.

“We’ve revealed the promising new potential for a safe and widely used medication, which could be life-changing for patients at risk of dementia and their families. For those with type 2 diabetes, metformin may add something extra to standard glucose-lowering in diabetes care: a benefit for cognitive health.” Katherine Samaras, PhD, Garvan Institute of Medical Research.

Read full article here.


ALSO READ

RELATED: Common diabetes drug reverses inflammation in the liver

RELATED: Metformin and cancer

RELATED: Metformin and heart problems

RELATED: Metformin and weight loss

RELATED: Re-purposing drugs

RELATED: In the study of 338 patients admitted in Northern Italy, those who were given sitagliptin (Januvia) on top of standard-of-care insulin at the time of hospitalization saw significantly lower odds of in-hospital death versus those on standard of care alone. This equated to an 18% mortality rate among COVID-19 patients with type 2 diabetes on sitagliptin versus a 37% mortality rate among those on standard of care. Diabetes Drug Linked With Lower Mortality in Patients With T2D and COVID-19